NewsRoom Articles - Page 22 of 115 - CanadianCannabisWire

FridayMar 18, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Imports First CBD Products from Colombia Operations to U.S., with National Distribution Boost from Recent JustCBD Acquisition

Flora Growth is a cannabis cultivator and distributor operating a 100-hectare (about 247-acre) harvesting site called Cosechemos in central Colombia’s favorable growing climate Flora Growth has completed its first import of CBD-containing food and beverage products into the United States under its Mambe brand, thanks to Colombian regulatory changes in recent months allowing cannabis product exports Flora has filed licenses for 23 cannabinoid-infused food and beverage products with Colombia’s INVIMA food and drug regulatory body Imported Flora products will take advantage of the company’s U.S. distribution network customer database, which nearly doubled with last month’s acquisition of established CPG brand…

ThursdayMar 10, 2022 11:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Builds Quality, Consistency in Florida, Michigan Operations

Red White & Bloom Brands is a cannabis and hemp multi-state operator, focused on product consistency and quality, critical to the developing cannabis market that is rapidly growing state by state The company’s successes in Michigan, a leading U.S. cannabis market, include the acquisition of full licensing, a 15,000-square-foot manufacturing and distribution facility, and more than 20 new potential locations for cultivation and dispensaries In Florida, RWB is building on its acquisition of a 45,000-square-foot cultivation facility to provide premium inventory to several existing dispensaries and new sites expected to open during this year’s Q1 Mainstream wellness consumers have cast…

ThursdayMar 10, 2022 11:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), a Global Innovator in Drug Delivery Platforms

Lexaria’s patented DehydraTECH technology proved effective for sildenafil delivery in animal study PDE5-A21-1 The company also made some notable strides with its HYPER-H21-4 clinical study on hypertension and heart disease treatment using DehydraTECH-CBD By doing so, it hopes to capitalize on the growing cardiovascular drugs market, which is projected to be valued at $107.8 billion by 2025 (https://cnw.fm/8bk1Y) With the success of its studies thus far, the company seeks to conduct even more trials over the 2022 calendar year Lexaria Bioscience (NASDAQ: LEXX) has, since its inception, remained committed to enhancing the speed and efficiency of orally-delivered fat-soluble active molecules…

WednesdayMar 09, 2022 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Updates Recent Product Diversification Efforts and Strategic Acquisitions Developments; Announces VP Of Sales & Marketing Appointment

In a recent update, InMed Pharmaceuticals president and CEO, Eric A. Adams, lauded the company’s progress and achievements so far, particularly with its product diversification and strategic acquisitions Adams noted the company’s commitment to launching more products and executing more programs to continue growing its product portfolio InMed also announced the appointment of Gerald (“Jerry”) P. Griffin III as Vice President of Sales and Marketing at BayMedica, its wholly-owned subsidiary In a conference call and webcast on February 15, 2022, Eric A. Adams, President and Chief Executive Officer of InMed Pharmaceuticals (NASDAQ: INM), emphasized the company’s successful product diversification and…

WednesdayMar 09, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strengthens Foothold in U.S. Wellness Market with Acquisition of JustCBD, Appoints Jessie Casner as CMO

Flora Growth owns and operates a portfolio of brands offering wholesale products, consumer packaged goods, or pharmaceutical and medical products The three-pronged operational approach has allowed the company to substantially expand and accelerate its revenue growth over the short term Recently, Flora Growth added yet another brand, JustCBD, to its portfolio; JustCBD’s performance is expected to immediately contribute to FLGC’s 2022 revenues and earnings Flora Growth also appointed Jessie Casner as the Chief Marketing Officer; Ms. Casner will lead communications, narrative building, and consumer marketing strategies, in addition to crafting brand awareness activities Founded on the premise of becoming a…

FridayMar 04, 2022 9:15 am

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infection Most recently, the company reported successes in increasing the speed and effectiveness in a drug treating erectile dysfunction (“ED”) in laboratory animals Lexaria is preparing an investigational new drug (“IND”) application for its hypertension line of study with the aim of achieving a new drug application (“NDA”) approval from…

WednesdayMar 02, 2022 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market

Over 140 rare cannabinoids exist in the cannabis plant – some with the potential to have more therapeutic benefits than those cannabinoids found prominently in the plant InMed and subsidiary BayMedica plan to release several rare cannabinoid products in the first half of 2022 Combination of complementary InMed and BayMedica business models key to increasing shareholders’ value In 2020, the global health and wellness market reached $4.436 trillion and is expected to grow at a CAGR of 5.5% from 2021 to 2030, resulting in an estimated value of $7.7 trillion by the end of the forecasted period (https://cnw.fm/hbx1E). The primary…

TuesdayMar 01, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Now Controls All Aspects of its Michigan Operations Following PharmaCo’s Acquisition

RWB has received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company This acquisition opens RWB to over 22 properties, including dispensaries and cultivation sites, giving it complete control of all its operations, from cultivating the product to selling it It marks a key milestone for the company and its shareholders as it continues to execute key components of its growth strategy For the 2022 calendar year, the company looks to extend its branded product lines, update its dispensaries, create supply chain efficiencies, and grow revenue and profitability Red White & Bloom Brands (CSE: RWB) (OTCQX:…

MondayFeb 28, 2022 9:15 am

As It Targets Multiple Large Market Opportunities, Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Leveraging Elaborate Studies to Progressively Remove Risks Associated with Commercialization, Regulation

Leveraging the versatility and benefits of its DehydraTECH(TM) technology, Lexaria is targeting multiple large market opportunities as it attempts to ensure it has multiple paths to success The technology aims to help companies offering oral drugs, supplements, and nicotine formulations to improve the effectiveness of their existing or planned products Lexaria has undertaken various studies whose findings show the benefits of DehydraTECH-processed products relative to controls The company intends to use the positive results from its studies to incrementally remove risks associated with commercialization and regulation Lexaria Bioscience (NASDAQ: LEXX), a global drug delivery technology company transforming existing consumer products…

FridayFeb 25, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreement with Israeli Product Distributor Artos Ltd. for Cannabis Sales

Flora Growth is a cannabis cultivator and distributor with a large cultivation site in central Colombia’s favorable growing climate Flora Growth recently announced an agreement with Israeli product distribution company Artos Ltd. to sell Flora’s high-THC cannabis flower to Israelis Colombia legalized the international export of cannabis flower last year for use in health and wellness industries Israelis comprise a large base of medical marijuana users and cannabis-based business enterprises Colombia and Israel began strengthening ties last year for promoting entrepreneurial innovation, and the agreement between Flora Growth and Artos builds on those state efforts Cannabis cultivator and brand builder…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000